Board of Directors, Strategic Advisors and Scientific Committee
Philippe Weigerstorfer
Chairman
An experienced board member with >35 years of experience in the healthcare space. Philippe has held numerous positions in various pharmaceutical companies with a successful track record in general management, marketing, sales and business development.
Philippe has acquired a deep understanding of the dermaceutical sector via his with previous roles as the Global Head of Therapeutic Area “Dermatology and Others” within Novartis Pharma (based in Basel, Switzerland) as well as with his current position as non-executive board member of Sonoma Pharmaceuticals Ltd, a USA based company that focuses on dermatology.
He also has vast experience in mergers, acquisitions and in/out-licensing of pharma products with deals ranging from 50 to almost 1 billion USD .
Tim Maiden
Director & Scientific Advisory Committee Member
As a practicing podiatrist and owner of The Foot Practice clinics across Singapore, Tim brings more than 10 years of experience with treating onychomycosis. In addition to his practices in Singapore, he runs a charity clinic, 1-2 times per month, in Sri Lanka.
Tim has been involved with research in onychomycosis and has presented at congresses and educational events around the world.
His strong business acumen via engagement in multiple start-up entities makes him a valuable addition to both our board of Directors as well as our Scientific Committee.
David Thornton
Strategic Advisor to the Board of Directors
Dave has over 15 years experience in the pharmaceutical industry having worked in multiple geographies with a strong working knowledge of product development, from molecule to market.
He has significant experience in supporting bio-pharma firms with projects ranging from clinical development strategies, Phase 3 trial execution through to commercial launches. With a vast network of Business Development Directors in the pharmaceutical sector he has experience introducing parties for in-licensing and out-licensing deals as well supporting mergers & acquisitions.
Dave is the Vice President at IQVIA Biotech responsible for multiple teams supporting biotech companies developing and launching compounds across Europe, Asia and the US.
Danny Goldman
Director
Danny is a registered chartered accountant and an entrepreneur with extensive experience in the finance sector and numerous companies in the capacity of chief financial officer.
He has over 5 years experience as the Managing Director in the pharmaceutical sector and is the co-founder and CEO of Xerion Limited based in Australia.
Jay Birnbaum
Head of the Scientific Advisory Committee
Jay is an experienced consultant in the dermatology sector who specialises in ethical and OTC drugs, medical devices and cosmetics. He has over 30 years of experience spanning the areas of discovery research, formulations, clinical R&D, regulatory and marketing.
He has been involved in the development and commercialization of numerous drug and consumer products and brands, including Lamisil - an antifungal product used to treat onychomycosis.
Jay is a member of numerous boards and scientific advisory panels for several companies and has extensive international relationships in both industry and academia.
Dheeraj Khiatani
Scientific Advisory Committee Member
Dr Dheeraj is a primary care clinician who has an additional degree in Psychiatry. His clinical interests span the field of Nutritional, Lifestyle and Aesthetic medicine. In his medical role he has managed many cases of onychomycosis and understands the difficulties associated with managing this disease.
He is also the Medical Director at The Iron Suites clinic and has experience in conducting clinical research as a lead Investigator.
Vic Ilag
Scientific Advisory Committee Member
Vic has over 20 years of biotech industry experience with more than 70 articles published in peer reviewed journals as well as presentations at medical conferences around the world. He has also been responsible for clinical studies including the early research work with Amycot.
In addition to his academic qualifications, including his PhD in Microbiology and Immunology, Vic is an adviser to the Philippines FDA plus sits on the review board of the journal International Journal of Molecular Sciences and the editorial board of New Biotechnology (which is the official journal of the European Federation of Biotechnology).
Vic has co-founded numerous companies including Xerion Limited where he is the Chief Scientific Officer.
